Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors.
Baars
J W
JW
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Wagstaff
J
J
Boven
E
E
Vermorken
J B
JB
van Groeningen
C J
CJ
Scheper
R J
RJ
Fonk
J C
JC
Nijman
H W
HW
Franks
C R
CR
Damsma
O
O
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage / Q000009:adverse effects; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage
D007376:Interleukin-2; D011994:Recombinant Proteins; D007371:Interferon-gamma